Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune ResponsesJohn L. Marshall, Jeffrey Schlom, Mary Ann Toomey et al.|Journal of Clinical Oncology|2000Cited by 357